JEFFERY WOO: Open Payments
NPI 1003037417 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,860 in 86 payments from 25 companies in 2025. Trend: 2023 $1,712 · 2024 $1,928 · 2025 $1,860
Food & beverage: $1,767Education: $94
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $205 |
| Neurocrine BioSciences, Inc. | 9 | $199 |
| Lilly USA, LLC | 10 | $186 |
| Astellas Pharma US Inc | 6 | $165 |
| AstraZeneca Pharmaceuticals LP | 7 | $120 |
| PFIZER INC. | 4 | $107 |
| Amgen Inc. | 5 | $84 |
| Teva Pharmaceuticals USA, Inc. | 3 | $83 |
| Xeris Pharmaceuticals, Inc. | 4 | $83 |
| Eisai Inc. | 3 | $82 |
Products named: INGREZZA, Rybelsus, NURTEC ODT, Veozah, KISUNLA, KEVEYIS, Leqembi, CAPLYTA.
Industry payments across MI — which companies pay providers there.
